Evidence map›Paper›PMID 40735006›Full record

ArticleJournal of open source software2023

CRE: An R package for interpretable discovery and inference of heterogeneous treatment effects.

Riccardo Cadei, Naeem Khoshnevis, Kwonsang Lee, Daniela Maria Garcia, Falco J Bargagli Stoffi

Abstract read
In one paragraph

Article in Journal of open source software, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Riccardo CadeiDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0003-2416-8943
Naeem KhoshnevisResearch Computing, Harvard University, Cambridge, Massachusetts, United States of America.ORCID 0000-0003-4315-1426
Kwonsang LeeDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0002-5823-4331
Daniela Maria GarciaDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0003-3226-3561
Falco J Bargagli StoffiDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, United States of America.ORCID 0000-0002-6131-8165

Funding

Containerizing tasks to ensure robust AI/ML data curation pipelines to estimate environmental disparities in the rural southR01MD016054 · NIMHD · YALE UNIVERSITY · PI Michelle L Bell, Nicole Deziel · 2022 to 2026
$4.3M
National Cohort Studies of Alzheimer's Disease, Related Dementias and Air PollutionR01AG066793 · NIA · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ZANOBETTI, ANTONELLA · 2020 to 2025
$4.2M
Environmental Health Disparities in an Older PopulationR01MD012769 · NIMHD · YALE UNIVERSITY · PI BELL, MICHELLE L · 2017 to 2021
$3.9M
Relationship Between Multiple Environmental Exposures and CVD Incidence and Survival: Vulnerability and SusceptibilityR01ES028033 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI DOMINICI, FRANCESCA, LADEN, FRANCINE · 2018 to 2022
$3.5M
Integrating Air Pollution Prediction Models: Uncertainty Quantification and Propagation in Health StudiesR01ES030616 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DOMINICI, FRANCESCA, KIOUMOURTZOGLOU, MARIANTHI-ANNA · 2020 to 2024
$3.1M
Causal Inference with Interference for Evaluating Air Quality PoliciesR01ES026217 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · PI ZIGLER, CORWIN MATTHEW · 2016 to 2021
$2.2M
NIA NIH HHS R01 AG066793NIEHS NIH HHS R01 ES026217NIEHS NIH HHS R01 ES028033NIEHS NIH HHS R01 ES030616NIMHD NIH HHS R01 MD012769NIMHD NIH HHS R01 MD016054
6 · The paper itself

Abstract

In health and social sciences, it is critically important to identify interpretable subgroups of the study population where a treatment has notable heterogeneity in the causal effects with respect to the average treatment effect (ATE). Several approaches have already been proposed for heterogeneous treatment effect (HTE) discovery, either estimating first the conditional average treatment effect (CATE) and identifying heterogeneous subgroups in a second stage (Bargagli-Stoffi et al., 2020, 2022; Foster et al., 2011; Hahn et al., 2020), either estimating directly these subgroups in a direct data-driven procedure (Nagpal et al., 2020; Wang & Rudin, 2022). Many of these methodologies are decision tree-based methodologies. Tree-based approaches are based on efficient and easily implementable recursive mathematical programming (e.g., HTE maximization), they can be easily tweaked and adapted to different scenarios depending on the research question of interest, and they guarantee a high degree of interpretability-i.e., the degree to which a human can understand the cause of a decision (Lakkaraju et al., 2016). Despite these appealing features, single-tree heterogeneity discovery is characterized by two main limitations: instability in the identification of the subgroups and reduced exploration of the potential heterogeneity. To accommodate these shortcomings, Bargagli-Stoffi et al. (2023) proposed Causal Rule Ensemble, a new method for interpretable HTE characterization in terms of decision rules, via an extensive exploration of heterogeneity patterns by an ensemble-of-trees approach. CRE is an R package providing a flexible implementation of Causal Rule Ensemble. The package allows for multiple variants of Causal Rule Ensemble algorithm, also including different internal individual average treatment effect (IATE) estimators-i.e., AIPW (Robins et al., 1994), Causal Forest (Athey et al., 2019), Causal BART (Hill, 2011), S-Learner (Hill, 2011), T-Learner (Hansotia & Rukstales, 2002), X-Learner (Künzel et al., 2019).

Identifiers

PMID40735006
PMCPMC12306571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.